COMPASS-CAT versus Khorana risk assessment model for predicting venous thromboembolic events in patients with non-small cell lung cancer on active treatment with chemotherapy and/or immunotherapy, the CK-RAM study

Details 詳細情報について

• CRID

  1360862720783681024

• DOI

  10.1007/s11239-023-02860-4

• ISSN

  1573742X

• Web Site

  https://link.springer.com/content/pdf/10.1007/s11239-023-02860-4.pdf

  https://link.springer.com/article/10.1007/s11239-023-02860-4/fulltext.html

• Data Source

  • Crossref